Financials Tenet Healthcare Corporation

Equities

THC

US88033G4073

Healthcare Facilities & Services

Market Closed - Nyse 21:00:02 17/07/2024 BST 5-day change 1st Jan Change
133.4 USD +0.03% Intraday chart for Tenet Healthcare Corporation +2.09% +76.56%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,951 4,213 8,751 5,275 7,674 13,034 - -
Enterprise Value (EV) 1 18,440 17,486 22,033 19,496 21,448 22,413 22,135 21,339
P/E ratio -17 x 10.6 x 9.7 x 12.9 x 13.2 x 4.78 x 15 x 13.5 x
Yield - - - - - - - -
Capitalization / Revenue 0.21 x 0.24 x 0.45 x 0.28 x 0.37 x 0.64 x 0.61 x 0.58 x
EV / Revenue 1 x 0.99 x 1.13 x 1.02 x 1.04 x 1.1 x 1.04 x 0.96 x
EV / EBITDA 6.81 x 5.56 x 6.33 x 5.62 x 6.06 x 6.16 x 5.85 x 5.29 x
EV / FCF 32.8 x 6.1 x 24.2 x 60.7 x 13.2 x 6.07 x 14.8 x 14.2 x
FCF Yield 3.05% 16.4% 4.13% 1.65% 7.57% 16.5% 6.76% 7.02%
Price to Book -10.7 x 151 x 8.52 x 2.03 x 2.42 x 2.42 x 2.09 x 1.82 x
Nbr of stocks (in thousands) 103,895 105,517 107,126 108,123 101,552 97,683 - -
Reference price 2 38.03 39.93 81.69 48.79 75.57 133.4 133.4 133.4
Announcement Date 24/02/20 09/02/21 07/02/22 09/02/23 08/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 18,479 17,640 19,485 19,174 20,548 20,439 21,272 22,314
EBITDA 1 2,706 3,146 3,483 3,469 3,541 3,636 3,783 4,034
EBIT 1 1,856 2,289 2,628 2,628 2,671 2,791 2,922 3,175
Operating Margin 10.04% 12.98% 13.49% 13.71% 13% 13.66% 13.74% 14.23%
Earnings before Tax (EBT) 1 296 671 1,888 1,344 1,617 4,400 2,058 2,273
Net income 1 -232 399 914 411 611 2,731 893.6 968.6
Net margin -1.26% 2.26% 4.69% 2.14% 2.97% 13.36% 4.2% 4.34%
EPS 2 -2.240 3.750 8.420 3.790 5.710 27.90 8.920 9.852
Free Cash Flow 1 563 2,867 910 321 1,623 3,695 1,496 1,498
FCF margin 3.05% 16.25% 4.67% 1.67% 7.9% 18.08% 7.03% 6.71%
FCF Conversion (EBITDA) 20.81% 91.13% 26.13% 9.25% 45.83% 101.62% 39.53% 37.13%
FCF Conversion (Net income) - 718.55% 99.56% 78.1% 265.63% 135.3% 167.36% 154.65%
Dividend per Share 2 - - - - - - - -
Announcement Date 24/02/20 09/02/21 07/02/22 09/02/23 08/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,856 4,745 4,638 4,801 4,990 5,021 5,082 5,066 5,379 5,368 5,003 4,889 5,172 5,410 5,230
EBITDA 1 1,017 888 843 841 897 832 843 854 1,012 1,024 869.2 825.3 933.1 952.3 913.5
EBIT 1 816 685 627 632 684 615 630 630 796 816 657.6 622.3 725.2 740.1 702.4
Operating Margin 16.8% 14.44% 13.52% 13.16% 13.71% 12.25% 12.4% 12.44% 14.8% 15.2% 13.14% 12.73% 14.02% 13.68% 13.43%
Earnings before Tax (EBT) 1 528 378 265 380 321 380 373 345 519 3,084 433.3 403 531 486.7 474.7
Net income 1 249 140 38 131 102 143 123 101 244 2,151 189.2 163.8 229 216.5 205.8
Net margin 5.13% 2.95% 0.82% 2.73% 2.04% 2.85% 2.42% 1.99% 4.54% 40.07% 3.78% 3.35% 4.43% 4% 3.93%
EPS 2 2.290 1.280 0.3500 1.160 0.9200 1.320 1.150 0.9400 2.300 21.38 1.827 1.678 2.215 2.286 2.052
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 07/02/22 20/04/22 21/07/22 20/10/22 09/02/23 25/04/23 31/07/23 30/10/23 08/02/24 30/04/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 14,489 13,273 13,282 14,221 13,774 9,379 9,101 8,306
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 5.354 x 4.219 x 3.813 x 4.099 x 3.89 x 2.579 x 2.406 x 2.059 x
Free Cash Flow 1 563 2,867 910 321 1,623 3,695 1,496 1,498
ROE (net income / shareholders' equity) 6.98% 31.5% 173% 68.6% 44.4% 26% 15.3% 15.6%
ROA (Net income/ Total Assets) 1.23% 3.34% 3.34% 2.72% 2.2% 5.21% 3.04% 3.17%
Assets 1 -18,891 11,958 27,342 15,118 27,734 52,373 29,400 30,602
Book Value Per Share 2 -3.560 0.2600 9.590 24.00 31.20 55.20 63.80 73.40
Cash Flow per Share 2 11.90 32.10 14.40 9.800 22.70 19.80 19.70 21.00
Capex 1 670 540 658 762 751 825 867 912
Capex / Sales 3.63% 3.06% 3.38% 3.97% 3.65% 4.04% 4.08% 4.09%
Announcement Date 24/02/20 09/02/21 07/02/22 09/02/23 08/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
133.4 USD
Average target price
144.4 USD
Spread / Average Target
+8.21%
Consensus
  1. Stock Market
  2. Equities
  3. THC Stock
  4. Financials Tenet Healthcare Corporation